Industry news, page-778

I believe we can, they just need to employ or spend a little on someone who know's how to attract new investors both locally and internationally.

Im not against holding off approaching BP until the data is sufficient, actually very much for that. But its clear not enough is being done to promote Zantrene as a financial opportunity to people who have money.

That's why we get a conference here, or a 30 min presentation there. To the same Media we have seen over the last few years. That's just updating a bunch of people who if weren't interested or invested by now probably wont be after the 4th presso.

Hopefully they stop trying to promote it themselves and put a little spend on someone who isn't caught up in the science. Its not like as soon as they open the marketing flood gates the sharks swarm in, it always takes time or longer than people expect. RAC would know if pharma was interested and it would take months to do the due diligence and make a sale that was actually taken seriously.

Daniel has the register and can see who the longs and sticky shareholders are
I think shareholders have proven by holding on this long that we are not planning to let it go for a song so RAC need to trust shareholders that they can go and push it and we will take management advice if an offer comes in low.